Published in Biochem Biophys Res Commun on December 16, 1987
Human serum activities against Hemophilus influenzae, type b. J Clin Invest (1972) 7.85
The role of superoxide anion generation in phagocytic bactericidal activity. Studies with normal and chronic granulomatous disease leukocytes. J Clin Invest (1975) 7.40
Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) (2000) 7.17
Increased superoxide anion production by immunologically activated and chemically elicited macrophages. J Exp Med (1978) 6.50
Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide. Am J Pathol (1985) 5.02
The enhancement of bacterial phagocytosis by serum. The role of complement components and two cofactors. J Exp Med (1969) 4.96
Priming of neutrophils for enhanced release of oxygen metabolites by bacterial lipopolysaccharide. Evidence for increased activity of the superoxide-producing enzyme. J Exp Med (1984) 3.79
Effect of phorbol myristate acetate on the oxidative metabolism of human polymorphonuclear leukocytes. Blood (1976) 3.34
Generation of superoxide anion and chemiluminescence by human monocytes during phagocytosis and on contact with surface-bound immunoglobulin G. J Exp Med (1976) 3.19
Increased production of superoxide anion by macrophages exposed in vitro to muramyl dipeptide or lipopolysaccharide. J Exp Med (1980) 3.13
Efficacy of a therapeutic cocaine vaccine in rodent models. Nat Med (1996) 3.11
An abnormality of the alternate pathway of complement activation in sickle-cell disease. N Engl J Med (1973) 3.11
Macrophage microbicidal activity. Correlation between phagocytosis-associated oxidative metabolism and the killing of Candida by macrophages. J Exp Med (1980) 2.96
Tissue injury in inflammation. Oxidants, proteinases, and cationic proteins. J Clin Invest (1987) 2.93
Studies in vivo and in vitro on an abnormality in the metabolism of C3 in a patient with increased susceptibility to infection. J Clin Invest (1970) 2.92
Elaboration of toxic oxygen by-products by neutrophils in a model of immune complex disease. J Clin Invest (1976) 2.85
Immunization of humans with polyribophosphate, the capsular antigen of Hemophilus influenzae, type b. J Clin Invest (1972) 2.81
Lactoferrin enhances hydroxyl radical production by human neutrophils, neutrophil particulate fractions, and an enzymatic generating system. J Clin Invest (1981) 2.66
Preclinical evaluation of a rheolytic catheter for percutaneous coronary artery/saphenous vein graft thrombectomy. J Invasive Cardiol (1999) 2.66
Role of binding through C3b and IgG in polymorphonuclear neutrophil function: studies with trypsin-generated C3b. J Immunol (1979) 2.47
The role of superoxide anion and hydrogen peroxide in phagocytosis-associated oxidative metabolic reactions. J Clin Invest (1975) 2.40
Patients' perspectives on the management of emotional distress in primary care settings. J Gen Intern Med (1997) 2.35
Biologial effects of the human complement fragments C5a and C5ades Arg on neutrophil function. Immunopharmacology (1980) 2.35
Inhibition of phagocytosis-associated chemiluminescence by superoxide dismutase. Infect Immun (1974) 2.26
Neutrophil-mediated injury to endothelial cells. Enhancement by endotoxin and essential role of neutrophil elastase. J Clin Invest (1986) 2.22
Cultured human monocytes require exposure to bacterial products to maintain an optimal oxygen radical response. J Immunol (1982) 2.19
Sleep disorders in the elderly. Am J Psychiatry (1988) 2.17
Prevalence of broad-host-range lytic bacteriophages of Sphaerotilus natans, Escherichia coli, and Pseudomonas aeruginosa. Appl Environ Microbiol (1998) 2.15
Increased susceptibility to infection associated with abnormalities of complement-mediated functions and of the third component of complement (C3). N Engl J Med (1970) 2.08
Oxygen metabolism and the microbicidal activity of macrophages. Fed Proc (1978) 2.04
Isolation and preliminary characterization of bacteriophage phi-mu-4. J Bacteriol (1964) 1.99
Monocyte function in children with neutropenia and chronic infections. Blood (1972) 1.98
Improvement of leukocyte bactericidal activity in chronic granulomatous disease. Blood (1970) 1.90
Dissociation of phagocytosis from stimulation of the oxidative metabolic burst in macrophages. J Exp Med (1984) 1.85
Activation of macrophages for enhanced release of superoxide anion and greater killing of Candida albicans by injection of muramyl dipeptide. J Exp Med (1980) 1.79
Chronic granulomatous disease: correlation between pathogenesis and clinical findings. Pediatrics (1971) 1.76
Evidence that nitric acid increases relative humidity in low-temperature cirrus clouds. Science (2004) 1.63
Characterization of human antibody to polyribophosphate, the capsular antigen of Hemophilus influenzae, type B. Clin Immunol Immunopathol (1973) 1.60
Superoxide dismutase activity in leukocytes. J Clin Invest (1974) 1.59
Mechanisms of host defense against Candida species. I. Phagocytosis by monocytes and monocyte-derived macrophages. J Immunol (1991) 1.58
Kinetic assessment of alternative complement pathway activity in a hemolytic system. II. Influence of antibody on alternative pathway activation. J Immunol (1978) 1.54
Lipopolysaccharide priming of human neutrophils for an enhanced respiratory burst. Role of intracellular free calcium. J Clin Invest (1989) 1.53
Enhancement of macrophage candidacidal activity by interferon-gamma. Increased phagocytosis, killing, and calcium signal mediated by a decreased number of mannose receptors. J Clin Invest (1993) 1.50
S-thiolation of glyceraldehyde-3-phosphate dehydrogenase induced by the phagocytosis-associated respiratory burst in blood monocytes. J Biol Chem (1994) 1.46
Secondary disorders of the complement system. Am J Dis Child (1989) 1.42
Metabolic and bactericidal activities of human eosinophils. Br J Haematol (1971) 1.41
Chronic granulomatous disease. Pediatr Clin North Am (1977) 1.39
An overview of infant mortality and birth defects in the United States. Teratology (1997) 1.38
Tubewell water quality and predictors of contamination in three flood-prone areas in Bangladesh. J Appl Microbiol (2008) 1.37
The host response to invasion by Streptococcus pneumoniae: protection and the pathogenesis to tissue damage. Rev Infect Dis (1981) 1.35
The priming of neutrophils by lipopolysaccharide for production of intracellular platelet-activating factor. Potential role in mediation of enhanced superoxide secretion. J Immunol (1988) 1.33
Immune response to acute otitis media in children. I. Serotypes isolated and serum and middle ear fluid antibody in pneumococcal otitis media. Infect Immun (1974) 1.30
Salicornia bigelovii Torr.: An Oilseed Halophyte for Seawater Irrigation. Science (1991) 1.29
Clinical features and current management of chronic granulomatous disease. Hematol Oncol Clin North Am (1988) 1.28
Separation of serum bactericidal and opsonizing activities for Haemophilus influenzae type b. Infect Immun (1973) 1.27
Chronic neutropenia and abnormal cellular immunity in cartilage-hair hypoplasia. N Engl J Med (1970) 1.27
Complement and host defense against infection. J Pediatr (1977) 1.26
Effect of anti-inflammatory drugs and agents that elevate intracellular cyclic AMP on the release of toxic oxygen metabolites by phagocytes: studies in a model of tissue-bound IgG. Clin Immunol Immunopathol (1978) 1.26
Generation of chemiluminescence by a particulate fraction isolated from human neutrophils. Analysis of molecular events. J Clin Invest (1979) 1.26
S-thiolation of individual human neutrophil proteins including actin by stimulation of the respiratory burst: evidence against a role for glutathione disulfide. Arch Biochem Biophys (1994) 1.26
Comparative study of the metabolic and bactericidal characteristics of severely glucose-6-phosphate dehydrogenase-deficient polymorphonuclear leukocytes and leukocytes from children with chronic granulomatous disease. J Reticuloendothel Soc (1972) 1.25
Molecular basis for the enhanced respiratory burst of activated macrophages. Fed Proc (1985) 1.23
Paper replication method for isolation of radiation-sensitive mutants. Appl Environ Microbiol (1983) 1.23
Epidemiologic studies of Streptococcus pneumoniae in infants: antibody response to nasopharyngeal carriage of types 3, 19, and 23. J Infect Dis (1981) 1.21
Recurrent septicemia associated with congenital deficiency of C2 and partial deficiency of factor B and the alternative complement pathway. N Engl J Med (1978) 1.20
Activity of the alternative complement pathway after splenectomy: comparison to activity in sickle cell disease and hypogammaglobulinemia. J Pediatr (1979) 1.16
D2O-alanine exchange reactions catalyzed by alanine racemase and glutamic pyruvic transminase. Biochem Biophys Res Commun (1974) 1.16
Priming of macrophages for enhanced oxidative metabolism by exposure to proteolytic enzymes. J Exp Med (1981) 1.16
Drug therapy: Psychotropic drug use in the elderly (first of two parts). N Engl J Med (1983) 1.15
Activation of mouse peritoneal macrophages by lipopolysaccharide alters the kinetic parameters of the superoxide-producing NADPH oxidase. J Biol Chem (1983) 1.15
Physiochemical characterization of a neonatal calf diarrhea virus. Can J Comp Med (1973) 1.14
Chronic familial granulomatosis. Report of five cases and review of the literature. Am J Dis Child (1967) 1.13
Light-induced charge separation in anatase TiO2 particles. J Phys Chem B (2005) 1.13
Immunoglobulins of the middle ear fluid in acute otitis media: relationship to serum immunoglobulin concentrations and bacterial cultures. Infect Immun (1973) 1.12
Kinetic assessment of alternative complement pathway activity in a hemolytic system. I. Experimental and mathematical analyses. J Immunol (1978) 1.10
The immune response to acute otitis media in children. II. Serum and middle ear fluid antibody in otitis media due to Haemophilus influenza. J Infect Dis (1975) 1.09
Candidacidal mechanisms in the human neonate. Impaired IFN-gamma activation of macrophages in newborn infants. J Immunol (1994) 1.09
Training professionals to record proceedings of interdisciplinary team conferences. Appl Res Ment Retard (1985) 1.07
Strategies for counseling depressed patients by primary care physicians. J Gen Intern Med (1994) 1.06
Deficiency of NADPH oxidase activity in chronic granulomatous disease. J Pediatr (1977) 1.05
Chronic arthritis after rubella vaccination. Clin Infect Dis (1992) 1.04
Measurement of O2- secreted by monocytes and macrophages. Methods Enzymol (1984) 1.04
Increased susceptibility to infection in sickle cell disease: review of its occurrence and possible causes. South Med J (1974) 1.04
Mechanisms of host defense against Candida species. II. Biochemical basis for the killing of Candida by mononuclear phagocytes. J Immunol (1991) 1.04
Immune response to acute otitis media: association between middle ear fluid antibody and the clearing of clinical infection. J Clin Microbiol (1976) 1.04
Chronic granulomatous disease and Pneumocystis carinii pneumonia. Pediatrics (1982) 1.03
Respiratory burst enzyme in human neutrophils. Evidence for multiple mechanisms of activation. J Clin Invest (1981) 1.03
Test for carcinogenicity of metallic compounds by the pulmonary tumor response in strain A mice. Cancer Res (1976) 1.03
Quantifying stratospheric ozone in the upper troposphere with in situ measurements of HCl. Science (2004) 1.03
Injury patterns in recreational rock climbers. Am J Sports Med (1996) 1.02
Functional and biochemical studies of multinucleated giant cells derived from the culture of human monocytes. J Exp Med (1984) 1.02
Underrecognition of patients' psychosocial distress in a university hospital medical clinic. Am J Psychiatry (1983) 1.01
Enhancement by Ca2+ or Mg2+ of catalytic activity of the superoxide-producing NADPH oxidase in membrane fractions of human neutrophils and monocytes. J Biol Chem (1985) 1.00
Priming of neutrophils and macrophages for enhanced release of superoxide anion by the calcium ionophore ionomycin. Implications for regulation of the respiratory burst. J Biol Chem (1987) 0.99
Reversal of flecainide-induced ventricular arrhythmia by hypertonic sodium bicarbonate in dogs. Am J Emerg Med (1995) 0.97
Activation of the respiratory burst in macrophages. Phosphorylation specifically associated with Fc receptor-mediated stimulation. J Immunol (1988) 0.97
Residual pulmonary findings in clinical hyaline-membrane disease. N Engl J Med (1968) 0.97